NMM
DMAC icon

Naples Money Management’s DiaMedica Therapeutics DMAC Stock Holding History

Naples Money Management’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$8.66K Sell
2,068
-910
-31% -$3.36K 0.01% 200
2024
Q2 		$8.79K Hold
2,978
– – 0.01% 205
2024
Q1 		$8.25K Sell
2,978
-900
-23% -$2.61K 0.01% 215
2023
Q4 		$11K Buy
+3,878
New +$9.6K 0.01% 187

Other funds holding DMAC

CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Naples Money Management's DMAC Position: Q3 2024 in Review

Naples Money Management reduced its DiaMedica Therapeutics (DMAC) stake by 31% in Q3 2024, selling an estimated $3.36K and leaving 2,068 shares worth $8.66K. The position accounts for 0.01% of the portfolio, ranked #200.

Naples Money Management first reported a position in DMAC in Q4 2023 and has held it in 4 quarters since. The position peaked at $11K in Q4 2023. 40 funds tracked by Wall St. Rank hold DMAC as of Q3 2024.

  • Naples Money Management held 2,068 shares of DiaMedica Therapeutics worth $8.66K as of Q3 2024.
  • Naples Money Management sold 910 DiaMedica Therapeutics shares in Q3 2024, an estimated $3.36K.
  • DiaMedica Therapeutics made up 0.01% of Naples Money Management's portfolio in Q3 2024, its #200 holding.
  • Naples Money Management first reported a position in DiaMedica Therapeutics in Q4 2023 and has held it in 4 quarters since.
  • Naples Money Management's DiaMedica Therapeutics position peaked at $11K in Q4 2023.
  • 40 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q3 2024.

Based on Naples Money Management's 13F filing for Q3 2024, filed 12 Nov 2024.